circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axis
Journal of Cancer · 2024 · 15 (16) · 5451-5461
DOI: 10.7150/jca.99561 ↗At a glance
Journal article in Journal of Cancer, 2024. Written by Jianfeng Xu and 5 co-authors. Institution: Department of Urology, Jinjiang Municipal Hospital. No. 16, Luoshan Section, Jinguang Road, Luoshan Street, Jinjiang City, Quanzhou, Fujian, China. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Sažetak nije dostupan.
Subjects
Author keywords
Authors and institutions
- Department of Urology, Jinjiang Municipal Hospital. No. 16, Luoshan Section, Jinguang Road, Luoshan Street, Jinjiang City, Quanzhou, Fujian, China.
- Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China.
Cite
APA
Xu, J., Xu, S., Liu, W., Chen, J., Cai, L., & Zhuang, W. (2024). circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axis. Journal of Cancer, 15(16), 5451-5461. https://doi.org/10.7150/jca.99561
Vancouver
Xu J, Xu S, Liu W, Chen J, Cai L, Zhuang W. circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axis. Journal of Cancer. 2024;15(16):5451-5461. doi:10.7150/jca.99561
BibTeX
@article{Xu2024,
author = {Xu, Jianfeng and Xu, Siwei and Liu, Weihui and Chen, Jiabi and Cai, Longbo and Zhuang, Wei},
title = {circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axis},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {16},
pages = {5451--5461},
doi = {10.7150/jca.99561}
}
EUVIMED